Innate lymphoid cells in antitumor immunity.

Area of Science:

• Immunology
• Cancer Biology
• Cell Biology

Background:

• Innate lymphoid cells (ILCs) are a recently identified lymphocyte subset.
• ILCs function similarly to CD4 T helper cells but act locally and independently of antigens.
• Their role in immune responses, particularly in early stages, is increasingly recognized.

Purpose of the Study:

• To review the multifaceted role of ILCs in tumorigenesis.
• To explore how ILCs can either promote or suppress tumor development.
• To discuss emerging clinical strategies targeting ILCs for cancer therapy.

Main Methods:

• Literature review of studies investigating ILCs in cancer.
• Analysis of ILC function, cytokine profiles, and transcriptional regulation.
• Examination of the tumor microenvironment's influence on ILC activity.

Main Results:

• ILCs exhibit dual roles in cancer, potentially promoting or inhibiting tumor growth.
• Tumor outcomes are influenced by specific ILC subsets, released cytokines, and the tumor microenvironment.
• ILCs' antigen-independent, local action is critical in early immune responses.

Conclusions:

• ILCs are significant players in the complex landscape of cancer immunology.
• Understanding ILCs' context-dependent functions is crucial for developing effective cancer treatments.
• Targeting ILCs presents a promising frontier for novel antitumor therapies.